glp 1 overweight GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach Poll: 1 in 8 Adults

Dietary fat and gut microbiota interactions determine diet-induced obesity in mice

In this podcast episode, McCall McPherson, a medical professional from the Modern Thyroid Clinic, explores the benefits of GLP-1 agonists, originally developed for diabetes treatment, in aiding weight loss and improving overall health

Although numerous anti-depressive treatments are available, 30% of patients diagnosed with depression do not experience positive therapeutic effects with these therapies ( The gut is a key member of the gut-brain axis owing to its own enteric nervous system and its independent responses to the exterior environment and stress (Rao and Gershon, 2016)

Cohen, P

With over 11,000 patients served and thousands of pounds collectively lost, PharmaZee's track record speaks for itself

Nonalcoholic fatty liver disease (NAFLD) Affecting more than 30% of people worldwide, NAFLD is caused by the build-up of lipids within hepatic cells and has been linked to obesity, type 2 diabetes, and hyperlipidemia